Percutaneous Coronary Intervention Versus Surgery in Left Main Stenosis-A Meta-Analysis and Systematic Review of

Safi U Khan1, Hammad Rahman1, Adeel Arshad2

  • 1Guthrie Health System/Robert Packer Hospital, Sayre, PA, USA.

Heart, Lung & Circulation
|September 20, 2017
PubMed

Insights

Percutaneous coronary intervention (PCI) is safer for left main coronary artery disease initially, but coronary artery bypass graft (CABG) surgery shows better long-term results. Both treatments have comparable outcomes at one year.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Left main coronary artery (LMCA) disease poses significant risks.
  • Treatment decisions involve balancing procedural safety with long-term efficacy.
  • Percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) are primary treatment options.

Purpose of the Study:

  • To compare the safety and efficacy of PCI versus CABG for LMCA disease.
  • To evaluate short-term and long-term clinical outcomes.
  • To assess periprocedural adverse events associated with each modality.

Main Methods:

  • Systematic review and meta-analysis of six randomized controlled trials (RCTs).
  • Searched major databases: PubMed/Medline, Embase, and Cochrane Library.
  • Pooled estimates using random effects model; reported binary outcomes as risk ratios (RR) and continuous outcomes as mean differences (MD) with 95% confidence intervals (CI).

Main Results:

  • 3794 patients were randomized; mean age 64.7 years, 74.4% male, mean Logistic EURO score (LES) 2.9.
  • PCI showed reduced major adverse cardiovascular events (MACE) at 30 days (RR: 0.55; 95% CI, 0.41-0.75) but similar MACE at 1 year (RR: 1.15; 95% CI, 0.92-1.45).
  • CABG demonstrated superior 5-year MACE rates (RR: 1.32; 95% CI, 1.13-1.53), driven by higher target vessel revascularization (TVR) and myocardial infarction (MI) with PCI. PCI was safer periprocedurally, with lower rates of MI, stroke, bleeding, and transfusion needs.

Conclusions:

  • PCI offers reduced MACE at 30 days and comparable MACE at 1 year compared to CABG for LMCA disease.
  • CABG is more effective for mid- to long-term outcomes, particularly in reducing TVR and MI.
  • PCI is a safer procedure concerning periprocedural adverse events, including MI, stroke, and bleeding.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
342
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
398
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
839
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
321